| CASE REPORT |
|
| Year : 2012 | Volume
: 11
| Issue : 1 | Page : 30-32 |
|
|
Post-treatment Assessment of Glioblastoma Multiforme: Imaging with Fluorodeoxyglucose, Sestamibi, and Choline
Chjoong Howe Alvin Tan1, Eik Hock Andrew Tan2
1 Department of Diagnostic Radiology, Khoo Teck Purt Hospital, Singapore
2 Department of Nuclear Medicine and PET, Singapore General Hospital, Singapore
Correspondence Address:
Chjoong Howe Alvin Tan
Department of Diagnostic Radiology, Khoo Teck Puat Hospital, 90 Yishun Central, 768828
Singapore
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1450-1147.98745
|
|
|
Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults, and is generally of poor prognosis. The post-treatment assessment of GBMs is a known diagnostic issue, with problems in the differentiation of viable remnant tumor and post-treatment inflammatory changes. We present a case where various molecular tracers (fluorodeoxyglucose, choline, and methoxyisobutylisonitrile) were used in the post-treatment assessment of a patient with histologically proven GBM. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Users Online: 2802 
